BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6603097)

  • 1. Phenotypical, functional and chromosomal studies of lymphocytes from patients with infectious mononucleosis.
    Jensen JR; Bisballe S; Pedersen EB; Christensen KD; Thestrup-Pedersen K
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):9-14. PubMed ID: 6603097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired T lymphocyte colony formation in infectious mononucleosis: evidence for both monocyte and lymphocyte defects.
    Claësson MH; Andersen V
    Clin Exp Immunol; 1979 Dec; 38(3):483-91. PubMed ID: 317032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.
    Carney WP; Rubin RH; Hoffman RA; Hansen WP; Healey K; Hirsch MS
    J Immunol; 1981 Jun; 126(6):2114-6. PubMed ID: 6262407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis.
    Haynes BF; Schooley RT; Grouse JE; Payling-Wright CR; Dolin R; Fauci AS
    J Immunol; 1979 Feb; 122(2):699-702. PubMed ID: 216749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subpopulations of T lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis.
    Jensen JR; Cramers M; Thestrup-Pedersen K
    Clin Exp Immunol; 1981 Jul; 45(1):118-23. PubMed ID: 6458433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis.
    Carney WP; Iacoviello V; Hirsch MS
    J Immunol; 1983 Jan; 130(1):390-3. PubMed ID: 6292304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis.
    Crawford DH; Brickell P; Tidman N; McConnell I; Hoffbrand AV; Janossy G
    Clin Exp Immunol; 1981 Feb; 43(2):291-7. PubMed ID: 6456093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T gamma and T mu lymphocytes. Clinical and experimental studies of human T gamma and T mu lymphocytes participating in the immune response.
    Jensen JR
    Dan Med Bull; 1984 Apr; 31(2):73-89. PubMed ID: 6233103
    [No Abstract]   [Full Text] [Related]  

  • 9. T gamma cells in sarcoidosis: E rosetting monocytes suppress lymphocyte transformation.
    Johnson NM; Brostoff J; Hudspith BN; Boot JR; McNicol MW
    Clin Exp Immunol; 1981 Mar; 43(3):491-6. PubMed ID: 6974625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood lymphocytes in infectious mononucleosis share the following characteristics with activated T cells: natural attachment, stable E rosetting and glucocorticoid sensitivity.
    Galili U; Seeley J; Svedmyr E; Klein E; Klein G; Weiland O
    J Clin Lab Immunol; 1980 May; 3(3):153-8. PubMed ID: 6968353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
    Karwowska W; Kunicka A
    Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological profile of mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K; Ahrons S; Zachariae H
    Clin Exp Immunol; 1982 Nov; 50(2):397-405. PubMed ID: 6983938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.
    Victorino RM; Ryan P; Hughes GR; Hodgson HJ
    Clin Exp Immunol; 1982 Apr; 48(1):121-8. PubMed ID: 6211313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E-rosette test: variations in results using E from different sheep. Effect of FCS and of AET treatment.
    Naess A; Nyland H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):367-70. PubMed ID: 6608856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines.
    Bishop CJ; Moss DJ; Ryan JM; Burrows SR
    Clin Exp Immunol; 1985 Apr; 60(1):70-7. PubMed ID: 3874018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year prospective studies of the dynamics of B, T and null lymphocyte cell count in infectious mononucleosis.
    Janeczko J
    Acta Med Pol; 1985; 26(3-4):153-66. PubMed ID: 3879785
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of lymphocytotoxins in infectious mononucleosis: reduced lymphocyte killing in the acute phase.
    Quin JW; Charlesworth JA; Lee CH; Macdonald GJ
    Clin Exp Immunol; 1980 Mar; 39(3):588-92. PubMed ID: 6966547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocytes in infectious mononucleosis. I. T cell death in vitro.
    Moss DJ; Bishop CJ; Burrows SR; Ryan JM
    Clin Exp Immunol; 1985 Apr; 60(1):61-9. PubMed ID: 3874017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.